Method and composition for the treatment of inflammatory bowel disease
First Claim
Patent Images
1. A method for treating a patient having a condition characterized as inflammatory bowel disease comprising reducing cytokine inflammatory mediator activity by administering a dose of HGF effective to reduce the gene expression of cytokine inflammatory mediators.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to a method and composition for treating a patient having a condition characterized as inflammatory bowel disease with an effective dose of HGF. Mucosal damage and histologic lesions are reduced by administering HGF to patients suffering from the same. HGF may be administered to the patient lumenally or systemically.
-
Citations
8 Claims
- 1. A method for treating a patient having a condition characterized as inflammatory bowel disease comprising reducing cytokine inflammatory mediator activity by administering a dose of HGF effective to reduce the gene expression of cytokine inflammatory mediators.
Specification